Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny A Mammo

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Ocular Immunology and Inflammation|January 22, 2026
Impact of Treatment on Inflammatory Choroidal Neovascularization in Patients with SarcoidosisMatthew J Schulgit, Sunil K Srivastava, Gabriel Castilho S Barbosa, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2025
Early Outcomes of Faricimab Treatment for Diabetic Macular Edema in Patients Previously Treated With Anti-VEGF TherapyNitesh Mohan, Andrei Szigiato, Katherine E Talcott, et al.
Ophthalmology Science|January 19, 2026
Performance of GPT-5 Frontier Models in Ophthalmology Question AnsweringFares Antaki, David Mikhail, Daniel Milad, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Journal of Vitreoretinal Diseases|April 21, 2026
Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana VitrectomyJoseph R Abraham, Andrea Arline, Suraj Bala, et al.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
Ophthalmology. Retina|February 16, 2020
Late-Onset Retinal Findings and Complications in Untreated Retinopathy of PrematurityAbdualrahman E Hamad, Omar Moinuddin, Michael P Blair, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Ocular Immunology and Inflammation|January 22, 2026
Impact of Treatment on Inflammatory Choroidal Neovascularization in Patients with SarcoidosisMatthew J Schulgit, Sunil K Srivastava, Gabriel Castilho S Barbosa, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2025
Early Outcomes of Faricimab Treatment for Diabetic Macular Edema in Patients Previously Treated With Anti-VEGF TherapyNitesh Mohan, Andrei Szigiato, Katherine E Talcott, et al.
Ophthalmology Science|January 19, 2026
Performance of GPT-5 Frontier Models in Ophthalmology Question AnsweringFares Antaki, David Mikhail, Daniel Milad, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 17, 2026
Long-term Outcomes of Faricimab in Previously Treated Neovascular Age-related Macular DegenerationNitesh Mohan, Matthew J Schulgit, Victor Bellanda, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Journal of Vitreoretinal Diseases|April 21, 2026
Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana VitrectomyJoseph R Abraham, Andrea Arline, Suraj Bala, et al.
Ophthalmology. Retina|January 30, 2026
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional ElementsJustin C Muste, Matthew J Schulgit, Scott Perkins, et al.
Ophthalmology. Retina|February 16, 2020
Late-Onset Retinal Findings and Complications in Untreated Retinopathy of PrematurityAbdualrahman E Hamad, Omar Moinuddin, Michael P Blair, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 7